Septerna
Signal active
Organization
Contact Information
Overview
Septerna is a biotechnology company that discovers and advances novel small-molecule medicines targeting G protein-coupled receptors. The company's mission is to discover, develop, and commercialize medicines that improve the lives of patients by combining GPCR drug targets with the power of state-of-the-art small molecule drug discovery technologies. Septerna’s Native Complex platform is the engine that will make this happen.
About
Industries
Information Technology, Software, Biotechnology, Medical
Founded
2022
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Septerna headquartered in United States, North America, operates in the Information Technology, Software, Biotechnology, Medical sector. The company focuses on Information Technology and has secured $8.0B in funding across 32 round(s). With a team of 11-50 employees, Septerna is actively contributing to advancements in Information Technology. Their latest funding round, Series B - Septerna, raised $150.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
15
Lead Investors
0
Total Funding Amount
$250.0M
Details
2
Septerna has raised a total of $250.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 100.0M | ||
| 2023 | Early Stage Venture | 150.0M |
Investors
Septerna is funded by 32 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Driehaus Capital Management | - | FUNDING ROUND - Driehaus Capital Management | 150.0M |
| Biotechnology Value Fund | - | FUNDING ROUND - Biotechnology Value Fund | 150.0M |
| Soleus Capital | - | FUNDING ROUND - Soleus Capital | 150.0M |
| Septerna | - | FUNDING ROUND - Septerna | 150.0M |
Recent Activity
There is no recent news or activity for this profile.